MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Are Subjective Cognitive Complaints a predictor of future cognitive decline in Parkinson´s Disease? – A longitudinal study

M. Magriço, B. Meira, M. Fernandes, M. Saraiva, M. Salavisa, C. Borbinha, J. Maro, F. Ladeira, R. Barbosa, P. Bugalho (Lisboa, Portugal)

Meeting: 2022 International Congress

Abstract Number: 1231

Keywords: Cognitive dysfunction, Parkinson’s

Category: Parkinson's Disease: Cognitive functions

Objective: We aim to determine whether subjective cognitive complaints (SCC) may predict the development of cognitive impairment in Parkinson´s Disease (PD)

Background: Subjective cognitive complaints (SCC) are cognitive concerns frequently reported by PD patients. Increasing evidence suggests that SCC may be associated with a higher risk of future cognitive decline in PD. Nevertheless, the association between SCC and objective cognitive impairment has shown conflicting results.

Method: : Single-center, prospective, 4-year follow-up study of cognitively unimpaired PD patients at baseline. The patients were assessed at baseline with the hospital anxiety and depression scale (HADS), non-motor symptoms scale (NMSS), disability (Schawb and England [S&E]), motor symptoms (UPDRS III and Hoehn and Yahr [H&Y]). SCC was defined as a score ≥ 1 in non-motor symptoms scale (NMSS) domain 5. Montreal Cognitive Assessment Scale (MoCA) was used for cognitive assessment at baseline and follow-up. Cognitive impairment was defined as a score bellow cut-off for age and education. Logistic regression was used to test the correlation between the results of SCC (predictor) at baseline and the presence of cognitive impairment at follow-up (outcome), adjusting for baseline scores in MoCA, S&E, HY, UPDRS III and HADS (covariates). p<0.05 was considered significant.

Results: We included 41 cognitively unimpaired PD patients, off which 35 (85%) reported SCC at baseline. At 4-year follow-up, 17 (41.6%) were diagnosed with cognitive impairment (mild cognitive impairment or dementia) and 24 (58.4 %) remained cognitive unimpaired. At our study SCC were not associated with future cognitive decline.

Conclusion: Our findings did not support that SCC in cognitively unimpaired patients with PD acts as a predictor for future cognitive decline. Low predictive value could be associated with high prevalence of SCC at baseline.

To cite this abstract in AMA style:

M. Magriço, B. Meira, M. Fernandes, M. Saraiva, M. Salavisa, C. Borbinha, J. Maro, F. Ladeira, R. Barbosa, P. Bugalho. Are Subjective Cognitive Complaints a predictor of future cognitive decline in Parkinson´s Disease? – A longitudinal study [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/are-subjective-cognitive-complaints-a-predictor-of-future-cognitive-decline-in-parkinsons-disease-a-longitudinal-study/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/are-subjective-cognitive-complaints-a-predictor-of-future-cognitive-decline-in-parkinsons-disease-a-longitudinal-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley